As of June 30, 2026, Lana Medical Co. carries a market capitalization of 151.20M, placing it among publicly traded companies globally. Its enterprise value stands at 171.64M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 151.20M |
| Enterprise Value | 171.64M |
As of June 30, 2026, Lana Medical Co. has 54.00M shares outstanding.
| Shares Outstanding | 54.00M |
These figures are as of June 30, 2026.
| PB Ratio | 2.25 |
| P/TBV Ratio | 2.26 |
As of June 30, 2026, Lana Medical Co. maintains a current ratio of 1.62, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.62 |
| Quick Ratio | 0.04 |
| Debt / Equity | 34.67 |
As of the close on November 17, 2026, Lana Medical Co.'s stock has declined approximately 45.17% over the past 52 weeks. The 50-day moving average sits at 1.90, while the 200-day moving average is 2.44.
| 52-Week Price Change | -45.17% |
| 50-Day Moving Average | 1.90 |
| 200-Day Moving Average | 2.44 |
As of June 30, 2026, Lana Medical Co. holds 2.84M in cash and equivalents against 23.28M in total debt, resulting in a net debt position of 11.11M. Total book value stands at 67.16M, with working capital of 39.81M providing operational flexibility.
| Cash & Cash Equivalents | 2.84M |
| Total Debt | 23.28M |
| Net Debt | 11.11M |
| Equity (Book Value) | 67.16M |
| Book Value Per Share | 1.24 |
| Working Capital | 39.81M |
Lana Medical Co.'s most recent stock split took place on November 13, 2025 with a 1:10 split ratio.
| Last Split Date | 11/13/2025 |
| Split Ratio | 1:10 |
Already premium?